Cefprozil
Cefprozil (Cefzil - Bristol-Myers Squibb), a new oral second-generation cephalosporin, was recently released in the USA for treatment of pharyngitis, bronchitis, otitis media, and skin and skin-structure infections....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Cefprozil
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 873
Article Code: 873c
Date: June 26, 1992
Volume: 34
Pages: 63-64
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 873
Article Code: 873c
Date: June 26, 1992
Volume: 34
Pages: 63-64
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)